TY - JOUR
T1 - Preoperative renal dysfunction and long-term survival after surgery for non–small cell lung cancer
AU - Japanese Joint Committee of Lung Cancer Registry
AU - Saito, Tomohito
AU - Murakawa, Tomohiro
AU - Shintani, Yasushi
AU - Okami, Jiro
AU - Miyaoka, Etsuo
AU - Yoshino, Ichiro
AU - Date, Hiroshi
AU - Ito, Hiroyuki
AU - Ohtsuka, Takashi
AU - Toyooka, Shinichi
AU - Mori, Takeshi
AU - Watanabe, Shun ichi
AU - Asamura, Hisao
AU - Chida, Masayuki
AU - Endo, Shunsuke
AU - Kadokura, Mitsutaka
AU - Nakanishi, Ryoichi
N1 - Funding Information:
The authors thank the working group members of this registry and all of the contributors at the participating institutions. The Japanese Joint Committee of Lung Cancer Registry and this study were supported by the Japan Lung Cancer Society , the Japanese Association for Chest Surgery , the Japanese Respiratory Society , the Japan Society for Respiratory Endoscopy , and the Japanese Association for Thoracic Surgery . The authors also thank Editage ( www.editage.com ) for English language editing.
Publisher Copyright:
© 2021 The American Association for Thoracic Surgery
PY - 2021
Y1 - 2021
N2 - Objective: To investigate the association of preoperative renal dysfunction and long-term outcomes following lung cancer surgery. Methods: Using the Japanese Lung Cancer Registry data, we retrospectively examined 16,377 patients who underwent surgery for non–small cell lung cancer during 2010. Patients' renal function status was categorized as follows: serum creatinine <1.5 mg/dL (control, n = 16,169), serum creatinine ≥1.5 mg/dL with no dialysis (nondialysis-dependent chronic kidney disease, n = 113), and dialysis-dependent end-stage renal disease (n = 95). The association of patients' characteristics with overall survival was evaluated using multivariate Cox proportional hazard model. Results: The 5-year overall survival rates in patients with dialysis-dependent end-stage renal disease and with nondialysis-dependent chronic kidney disease were significantly worse than that in the control group (52.9% and 57.5% vs 78.0%; P <.001 for both comparisons), but were comparable to the reported 5-year overall survival rates in the natural history of end-stage renal disease (∼60%) and moderate to severe chronic kidney disease (∼50%). Cancer causes not related to lung cancer accounted for 62.2% of deaths in dialysis-dependent end-stage renal disease, which was more frequent than that in the control group (P =.002). Dialysis-dependent end-stage renal disease and nondialysis-dependent chronic kidney disease were independent risk factors for overall survival after lung cancer surgery (hazard ratio, 2.05 [P <.001] and hazard ratio, 2.04 [P =.001], respectively). Conclusions: Preoperative renal dysfunction may be adversely associated with overall survival after lung cancer surgery. Our findings could aid patients to set proper expectation of the risks and benefits about surgery for lung cancer.
AB - Objective: To investigate the association of preoperative renal dysfunction and long-term outcomes following lung cancer surgery. Methods: Using the Japanese Lung Cancer Registry data, we retrospectively examined 16,377 patients who underwent surgery for non–small cell lung cancer during 2010. Patients' renal function status was categorized as follows: serum creatinine <1.5 mg/dL (control, n = 16,169), serum creatinine ≥1.5 mg/dL with no dialysis (nondialysis-dependent chronic kidney disease, n = 113), and dialysis-dependent end-stage renal disease (n = 95). The association of patients' characteristics with overall survival was evaluated using multivariate Cox proportional hazard model. Results: The 5-year overall survival rates in patients with dialysis-dependent end-stage renal disease and with nondialysis-dependent chronic kidney disease were significantly worse than that in the control group (52.9% and 57.5% vs 78.0%; P <.001 for both comparisons), but were comparable to the reported 5-year overall survival rates in the natural history of end-stage renal disease (∼60%) and moderate to severe chronic kidney disease (∼50%). Cancer causes not related to lung cancer accounted for 62.2% of deaths in dialysis-dependent end-stage renal disease, which was more frequent than that in the control group (P =.002). Dialysis-dependent end-stage renal disease and nondialysis-dependent chronic kidney disease were independent risk factors for overall survival after lung cancer surgery (hazard ratio, 2.05 [P <.001] and hazard ratio, 2.04 [P =.001], respectively). Conclusions: Preoperative renal dysfunction may be adversely associated with overall survival after lung cancer surgery. Our findings could aid patients to set proper expectation of the risks and benefits about surgery for lung cancer.
KW - chronic kidney disease
KW - end-stage renal disease
KW - long-term survival
KW - non–small cell lung cancer
KW - renal dysfunction
UR - http://www.scopus.com/inward/record.url?scp=85116006387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85116006387&partnerID=8YFLogxK
U2 - 10.1016/j.jtcvs.2021.09.008
DO - 10.1016/j.jtcvs.2021.09.008
M3 - Article
C2 - 34600766
AN - SCOPUS:85116006387
SN - 0022-5223
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
ER -